Abstract
Chitosan (CS) based nanocarriers have been extensively studied starting from early 90s. The unique properties of CS and in particular its capability to interact with various epithelia and its mucoadhesion potential have attracted many researchers. The mild preparation conditions of CS nanosystems offer the opportunities to load stress sensitive hydrophilic macromolecules such as proteins and genetic materials. Moreover CS nanosystems are able to protect their cargo from the environment (pH, enzymes). The safety issues related to this polymer seem in part overcome at least for CS as polymeric solution. For this reason skin and mucosae, in particular buccal and vaginal ones, seem the more promising administration routes with lower technical and regulatory challenges. Even if several papers focused on CS nanocarriers for skin and mucosal (buccal and vaginal) administration have been published, other work should be done aiming at optimizing CS nanocarriers in view of clinical applications.
Keywords: Buccal and vaginal mucosae, Chitosan, Local and systemic delivery, Nanoparticles, Skin.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Opportunities Offered by Chitosan-Based Nanotechnology in Mucosal/ Skin Drug Delivery
Volume: 15 Issue: 4
Author(s): G. Sandri, M.C. Bonferoni, F. Ferrari, S. Rossi, M. Mori and C. Caramella
Affiliation:
Keywords: Buccal and vaginal mucosae, Chitosan, Local and systemic delivery, Nanoparticles, Skin.
Abstract: Chitosan (CS) based nanocarriers have been extensively studied starting from early 90s. The unique properties of CS and in particular its capability to interact with various epithelia and its mucoadhesion potential have attracted many researchers. The mild preparation conditions of CS nanosystems offer the opportunities to load stress sensitive hydrophilic macromolecules such as proteins and genetic materials. Moreover CS nanosystems are able to protect their cargo from the environment (pH, enzymes). The safety issues related to this polymer seem in part overcome at least for CS as polymeric solution. For this reason skin and mucosae, in particular buccal and vaginal ones, seem the more promising administration routes with lower technical and regulatory challenges. Even if several papers focused on CS nanocarriers for skin and mucosal (buccal and vaginal) administration have been published, other work should be done aiming at optimizing CS nanocarriers in view of clinical applications.
Export Options
About this article
Cite this article as:
Sandri G., Bonferoni M.C., Ferrari F., Rossi S., Mori M. and Caramella C., Opportunities Offered by Chitosan-Based Nanotechnology in Mucosal/ Skin Drug Delivery, Current Topics in Medicinal Chemistry 2015; 15 (4) . https://dx.doi.org/10.2174/1568026615666150108124122
DOI https://dx.doi.org/10.2174/1568026615666150108124122 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mechanisms And Prevention Of TAVI-Related Cerebrovascular Events
Current Pharmaceutical Design Nutritional Requirements for Maternal and Newborn Health
Current Women`s Health Reviews The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond
Current Molecular Imaging (Discontinued) Detecting the Association Between Residual Thrombus and Post-thrombotic Classification of Chronic Venous Disease with Range Regression
Reviews on Recent Clinical Trials Alkannins and Shikonins: A New Class of Wound Healing Agents
Current Medicinal Chemistry Topics of Physiological and Pathophysiological Functions of Lymphatics
Current Molecular Medicine The Role of Prostaglandins in Liver Ischemia-Reperfusion Injury
Current Pharmaceutical Design Platelets and Vascular Risk: An Option for Treatment
Current Pharmaceutical Design Antigen-specific Immunotherapy in Ovarian Cancer and p53 as Tumor Antigen
Current Pharmaceutical Design Treatment of Hypertensive Complications in Pregnancy
Current Pharmaceutical Design Polymeric Micelles for Ocular Delivery: Progress and Issues
Pharmaceutical Nanotechnology Inflammatory Syndrome in Chronic Kidney Disease: Pathogenesis and Influence on Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) Short Radius Centrifuges – A New Approach for Life Science Experiments Under Hyper-g Conditions for Applications in Space and Beyond
Recent Patents on Space Technology Gene Therapy in Liver Diseases: State-of-the-Art and Future Perspectives
Current Gene Therapy Indication-oriented Ovulation Induction in Assisted Reproduction
Current Women`s Health Reviews Therapeutic Approaches in the Stimulation of the Coronary Collateral Circulation
Current Cardiology Reviews Relaxin as a Cardiovascular Hormone: Physiology, Pathophysiology and Therapeutic Promises
Cardiovascular & Hematological Agents in Medicinal Chemistry Current Evidence for Antithrombotic Therapy after Peripheral Vascular Interventions
Current Vascular Pharmacology Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Research
Current Pharmaceutical Design Glycaemic Variability and Pancreatic ß-cell Dysfunction
Current Diabetes Reviews